$3.280
-0.197 (-6.02%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de ACRS por análisis de gráficos similares
Alphio's ACRS stock price prediction model matches the current Aclaris Therapeutics, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.28 (-0.08%). The 1-week path is $3.36 (+2.57%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Aclaris Therapeutics, Inc.?
Aclaris Therapeutics Inc is a good buy right now due to its current price of $3.28, which is significantly below analyst price targets of $10 and $13. The RSI is at 24.444, indicating that the stock is oversold, suggesting a potential rebound. Additionally, the company has a strong cash position of $170.6 million, which can support its upcoming clinical trials, providing a solid foundation for future growth. However, the main risk is the ongoing net losses, which reached $21.5 million in Q2 2026, indicating financial strain that could affect investor confidence.
ACRS cerró en $3.28 el Friday, tras bajar -6.02%
Aclaris Therapeutics, Inc. (ACRS) last closed at $3.28, losing -6.02%. These facts feed the 1-day and 1-week ACRS price prediction above.
Consenso de analistas
Aclaris Therapeutics, Inc. (ACRS): 6 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Aclaris Therapeutics, Inc. (ACRS) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de ACRS, ordenadas por similitud.
Análisis de estacionalidad de ACRS
Historically the probability of a positive October return for ACRS is 63.79%. December offers the highest probability of a positive month at 100.00%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de ACRS
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $0.71 | $0.73 | $0.81 | -77.81% |
| Nov 2026 | $0.58 | $0.73 | $0.88 | -77.81% |
| Dec 2026 | $0.77 | $0.84 | $0.91 | -74.28% |
En 2026, se proyecta que Aclaris Therapeutics, Inc. (ACRS) oscile entre $0.58 y $0.91.
Previsión mensual de Aclaris Therapeutics, Inc. para 2026
En Oct de 2026, se proyecta que Aclaris Therapeutics, Inc. promedie $0.73, con un mínimo de $0.71 y un máximo de $0.81.
En Nov de 2026, se proyecta que Aclaris Therapeutics, Inc. promedie $0.73, con un mínimo de $0.58 y un máximo de $0.88.
En Dec de 2026, se proyecta que Aclaris Therapeutics, Inc. promedie $0.84, con un mínimo de $0.77 y un máximo de $0.91.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.